Earnings Per Share

9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 12 – Earnings Per Share

The following table summarizes earnings per share calculations for the three and nine months ended September 30, 2019 and 2018:

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2019		2018		2019		2018
Basic (loss) earnings per common share
	Net (loss) income attributable to Quaker Chemical Corporation	$	(13,053)	$	19,690	$	16,382	$	51,668
	Less: loss (income) allocated to participating securities		46		(77)		(40)		(226)
	Net (loss) income available to common shareholders	$	(13,007)	$	19,613	$	16,342	$	51,442
	Basic weighted average common shares outstanding		16,185,724		13,278,259		14,271,121		13,263,417
Basic (loss) earnings per common share		$	(0.80)	$	1.48	$	1.15	$	3.88
Diluted (loss) earnings per common share
	Net (loss) income attributable to Quaker Chemical Corporation	$	(13,053)	$	19,690	$	16,382	$	51,668
	Less: loss (income) allocated to participating securities		46		(77)		(40)		(226)
	Net (loss) income available to common shareholders	$	(13,007)	$	19,613	$	16,342	$	51,442
	Basic weighted average common shares outstanding		16,185,724		13,278,259		14,271,121		13,263,417
	Effect of dilutive securities		—		37,282		42,850		33,928
	Diluted weighted average common shares outstanding		16,185,724		13,315,541		14,313,971		13,297,345
Diluted (loss) earnings per common share		$	(0.80)	$	1.47	$	1.14	$	3.87

The Company’s calculation of (loss) earnings per diluted share attributable to Quaker Chemical Corporation common shareholders for the three and nine months ended September 30, 2019 was impacted by the 4.3 million share issuance in connection with closing the Combination, comprising approximately 24.5% of the common stock of the Company as of September 30, 2019, as well as the variability of its reported earnings. Therefore, the per diluted share result for each of the first three quarters of 2019, as reported on a standalone basis, may not sum to the per diluted share result for the nine months ended September 30, 2019 .Certain stock options and restricted stock units are not included in the diluted (loss) earnings per share calculation because the effect would have been anti-dilutive. All of the Company’s potentially dilutive shares for the three months ended September 30, 2019 are anti-dilutive and not included in the dilutive (loss) earnings per share calculation because of the Company’s net loss for this period. The calculated amount of anti-dilutive shares not included in the diluted (loss) earnings per common share calculation was 1,905 for the three months ended September 30, 2019. There were no anti-dilutive shares for the nine months ended September 30, 2019. Comparatively, the calculated amount of anti-dilutive shares not included in the diluted earnings per share calculation was 718 and 3,480 for the three and nine months ended September 30, 2018, respectively.